Invention Grant
US09327019B2 Attenuated enterohemorrhagic E. coli-based vaccine vector and methods relating thereto
有权
减毒的肠出血性大肠杆菌疫苗载体及其相关方法
- Patent Title: Attenuated enterohemorrhagic E. coli-based vaccine vector and methods relating thereto
- Patent Title (中): 减毒的肠出血性大肠杆菌疫苗载体及其相关方法
-
Application No.: US13378116Application Date: 2010-06-30
-
Publication No.: US09327019B2Publication Date: 2016-05-03
- Inventor: Edgar C. Boedeker , Isaac Wyatt Byrd
- Applicant: Edgar C. Boedeker , Isaac Wyatt Byrd
- Applicant Address: US NM Albuquerque
- Assignee: STC.UNM
- Current Assignee: STC.UNM
- Current Assignee Address: US NM Albuquerque
- Agency: Procopio, Cory, Hargreaves & Savitch LLP
- Agent Patrric J. Rawlins
- International Application: PCT/US2010/040522 WO 20100630
- International Announcement: WO2011/002836 WO 20110106
- Main IPC: A61K39/00
- IPC: A61K39/00 ; A61K39/108

Abstract:
An attenuated enterohemorrhagic E. coli-based vaccine vector is disclosed. Enterotoxigenic E. coli colonization factor antigen 1 and the B subunit of E. coli heat labile toxin have been expressed in the attenuated enterohemorrhagic E. coli vector strain. Immunized animals are further protected against lethal and non lethal challenges with the enterotoxigenic E. coli strain. Immunization of mice with the vaccine construct induces mucosal antibody against both antigens, establishing the attenuated E. coli vector strain as a generally useful vector for presenting one or more antigens to a subject in a vaccine.
Public/Granted literature
- US20120093870A1 ATTENUATED ENTEROHEMORRHAGIC E.COLI-BASED VACCINE VECTOR AND METHODS RELATING THERETO Public/Granted day:2012-04-19
Information query